Immediately after birth, the baby boy developed life-threatening jaundice due to a rare blood type incompatibility between mother and child. Thanks to timely intervention, doctors were able to protect ...

Very rarely will a disease kill a person without giving adequate signs, especially if the person is listening appropriately to the body. Perhaps it is extremely contagious diseases like Ebola that can ...

The encouraging news is that liver damage can often be reversed with timely lifestyle changes, risk-factor control, and appropriate treatment.

TG Therapeutics, Inc. (“TG” or “the Company”), (NASDAQ: TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl ...

A multicenter study in Spain developed a new predictive model for surgical risk in patients with cirrhosis that may improve the prediction of postoperative mortality. The surgical risk prediction ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

To shed light on the possible causal link between type 2 diabetes and autoimmune liver disease, a research team led by Jinlong Liu, MD, from the Affiliated Hospital of Chengde Medical University and ...

The paving stones on Helena Hammer’s back patio were laid in place by her husband in the days before he died, his body weak ...

Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting(OXFORDSHIRE, England & ...

1. The introduction of HotSwap (TM) by CytoSorbents -- The New CytoSorb exchange system 2. The renewal of its long-standing partnership with Aferetica Srl in Italy, and 3. New clinical data ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...